To study the outcome of patients treated with a combination of two or three antimicrobial drugs for the treatment of pneumonia (developed during mechanical ventilator stay) caused by microbe Acinetobacter Baumannii resistant to the commonly used broad spectrum antimicrobial (carbepenem).
Phase 4
- Conditions
- Health Condition 1: A488- Other specified bacterial diseases
- Registration Number
- CTRI/2024/02/062539
- Lead Sponsor
- AIIMS JODHPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Having ventilator-associated pneumonia (VAP) infection due to Carbepenam resistant A. Baumannii (CRAB) during ICU stay.
Exclusion Criteria
1. Consent not obtained
2. Pregnant patients
3. Not treated for the infection
4. Infection not likely
5. Allergy to any drug used in the regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method